Associated Papers
Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir.
Canducci F et al.
The Journal of Infectious Diseases, 2011
Select a paper to view details